Article
AIP mutations impair AhR signaling in pituitary adenoma patients fibroblasts and in GH3 cells.
Endocrine-related cancer - 1 May 2016
Lecoq Anne-Lise, Viengchareun Say, Hage Mirella, Bouligand Jérôme, Young Jacques, Boutron Audrey, Zizzari Philippe, Lombès Marc, Chanson Philippe, Kamenický Peter
Abstract excerpt
Germline mutations in the aryl hydrocarbon receptor-interacting protein (AIP) gene predispose humans to pituitary adenomas through unknown molecular mechanisms. The best-known interacting partner of AIP is the aryl hydrocarbon receptor (AhR), a transcription factor that mediates the effects of xenobiotics implicated in carcinogenesis. As 75% of AIP mutations disrupt the physical and/or functional interaction with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
